SMTL ID : 4o09.1

Identification of novel HSP90 / isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington s disease

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

monomer

Ligands

1 x 2R6: 8-(2-methylpropyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one(Non-covalent)

2R6.1: 15 residues within 4Å: Chain A: N.48, S.49, D.51, A.52, D.90, M.95, L.100, L.104, A.108, G.132, F.135, Y.136, W.159, T.181, V.183 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:N.48, A:D.51, A:L.100, A:A.108, A:F.135, A:F.135, A:F.135, A:W.159, A:T.181, A:V.183 Hydrogen bonds: A:D.90, A:Y.136 Water bridges: A:G.94, A:T.181

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ernst, J.T. et al., Identification of Novel HSP90 alpha / beta Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington's Disease. J.Med.Chem. (2014)

Release Date

2014-04-09

Peptides

Heat shock protein HSP 90-alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Heat shock protein HSP 90-alpha

Related Entries With Identical Sequence